NEW YORK, Nov. 11 - Molecular Staging tomorrow will launch new DNA-amplification technology that it claims can yield an "unlimited amount" of DNA from a few cells.
Â
The technology, called Repli-g, is based on multiple-displacement technology it licensed from Yale University. Repli-g is "a substantial advancement over currently available whole genome-amplification methods, rapidly amplifying the genome with comprehensive loci coverage, minimal bias between any loci and yielding 10+ kb fragments in a simple, scalable reaction," Molecular Staging said in a statement in April..
Â
Stephen Kingsmore, COO of Molecular Staging, said the technology "will be enormously valuable" for researchers for whom obtaining additional sample blood is either too expensive or "impossible."
Â
Scientists will have the option either to send samples to Molecular Staging, which will perform the amplification, or to buy a Repli-f kit themselves, the company said.
Â
Last week, Molecular Staging, of New Haven, Conn., said it won $100,000 in a pair SBIR grants from the US Department of Energy. The grants will help the firm develop methods for microbial DNA amplification using the multiple displacement-amplification technology, and a biomarker chip for osteoarthritis.